Dilara McCauley
Cancer Clinic(US)
Publications by Year
Research Areas
Nuclear Structure and Function, Cancer-related Molecular Pathways, RNA Research and Splicing, Multiple Myeloma Research and Treatments, Cell death mechanisms and regulation
Most-Cited Works
- → Selective inhibitors of nuclear export show that CRM1/XPO1 is a target in chronic lymphocytic leukemia(2012)295 cited
- → Nucleo-cytoplasmic transport as a therapeutic target of cancer(2014)279 cited
- → First-in-Class, First-in-Human Phase I Study of Selinexor, a Selective Inhibitor of Nuclear Export, in Patients With Advanced Solid Tumors(2016)246 cited
- → Antileukemic activity of nuclear export inhibitors that spare normal hematopoietic cells(2012)191 cited
- → KPT‐330 inhibitor of CRM1 (XPO1)‐mediated nuclear export has selective anti‐leukaemic activity in preclinical models of T‐cell acute lymphoblastic leukaemia and acute myeloid leukaemia(2013)173 cited
- → Genome-wide studies in multiple myeloma identify XPO1/CRM1 as a critical target validated using the selective nuclear export inhibitor KPT-276(2013)163 cited
- → Sequential Loss of Tumor Vessel Pericytes and Endothelial Cells after Inhibition of Platelet-Derived Growth Factor B by Selective Aptamer AX102(2007)153 cited
- → Verdinexor, a Novel Selective Inhibitor of Nuclear Export, Reduces Influenza A Virus ReplicationIn VitroandIn Vivo(2014)114 cited
- → Preclinical Evaluation of the Novel, Orally Bioavailable Selective Inhibitor of Nuclear Export (SINE) KPT-335 in Spontaneous Canine Cancer: Results of a Phase I Study(2014)101 cited
- → XPO1 (CRM1) Inhibition Represses STAT3 Activation to Drive a Survivin-Dependent Oncogenic Switch in Triple-Negative Breast Cancer(2014)101 cited